{"organizations": [], "uuid": "37b5d5bef367ba9adae417e7706ea4cf5a438ac7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-dermira-initiates-mid-stage-study/brief-dermira-initiates-mid-stage-study-testing-eczema-treatment-idUSFWN1PQ18J", "country": "US", "domain_rank": 408, "title": "BRIEF-Dermira Initiates Mid-Stage Study Testing Eczema Treatment", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T15:42:00.000+02:00", "replies_count": 0, "uuid": "37b5d5bef367ba9adae417e7706ea4cf5a438ac7"}, "author": "", "url": "https://www.reuters.com/article/brief-dermira-initiates-mid-stage-study/brief-dermira-initiates-mid-stage-study-testing-eczema-treatment-idUSFWN1PQ18J", "ord_in_thread": 0, "title": "BRIEF-Dermira Initiates Mid-Stage Study Testing Eczema Treatment", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "dermira inc", "sentiment": "none"}, {"name": "czema treatment reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 31, 2018 / 1:44 PM / Updated 9 minutes ago BRIEF-Dermira Initiates Mid-Stage Study Testing Eczema Treatment Reuters Staff \nJan 31 (Reuters) - Dermira Inc: \n* DERMIRA INITIATES PHASE 2B DOSE-RANGING STUDY EVALUATING LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS \n* DERMIRA INC - ‍TOPLINE RESULTS FROM PHASE 2B DOSE-RANGING STUDY​ EXPECTED IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-31T15:42:00.000+02:00", "crawled": "2018-01-31T15:59:40.009+02:00", "highlightTitle": ""}